AFM
ACER

Anson Funds Management’s Acer Therapeutics Inc ACER Stock Holding History

Anson Funds Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-129,795
Closed -$120K – 183
2023
Q2 		$120K Hold
129,795
– – 0.02% 136
2023
Q1 		$98.5K Hold
129,795
– – 0.02% 172
2022
Q4 		$326K Buy
+129,795
New +$223K 0.05% 175

Other funds holding ACER

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Anson Funds Management's ACER Position: Q3 2023 in Review

Anson Funds Management sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 129,795 shares — an estimated $120K sold.

Anson Funds Management first reported a position in ACER in Q4 2022 and held it in 3 quarters. The position peaked at $326K in Q4 2022. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.

  • Anson Funds Management reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
  • Anson Funds Management sold 129,795 Acer Therapeutics Inc shares in Q3 2023, an estimated $120K.
  • Anson Funds Management first reported a position in Acer Therapeutics Inc in Q4 2022 and held it in 3 quarters.
  • Anson Funds Management's Acer Therapeutics Inc position peaked at $326K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.

Based on Anson Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.